Profile
Kyler Lei is currently Chief Financial Officer at NovaBridge Biosciences since 2025.
Formerly, Mr. Lei was Deputy General Manager & Head-Capital Markets at Sino Biopharmaceutical Ltd. from 2022 to 2025, Research Analyst at Daiwa Capital Markets (Hong Kong) Ltd. from 2020 to 2021, and Analyst at Macquarie Capital Ltd. from 2018 to 2020.
Education includes an undergraduate degree from The University of Hong Kong conferred in 2019 and a graduate degree from The Hong Kong University of Science & Technology conferred in 2022.
Kyler Lei active positions
| Companies | Position | Start |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Director of Finance/CFO | 15/10/2025 |
Former positions of Kyler Lei
| Companies | Position | End |
|---|---|---|
| SINO BIOPHARMACEUTICAL LIMITED | Corporate Officer/Principal | 30/09/2025 |
Daiwa Capital Markets (Hong Kong) Ltd.
Daiwa Capital Markets (Hong Kong) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 31/05/2021 |
Macquarie Capital Ltd.
Macquarie Capital Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 31/05/2020 |
Training of Kyler Lei
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Sino Biopharmaceutical Ltd.
Sino Biopharmaceutical Ltd. Pharmaceuticals: MajorHealth Technology Operates as an investment holding company, which engages in the manufacturing and selling of pharmaceutical products | Health Technology |
University of Hong Kong
University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Macquarie Capital Ltd.
Macquarie Capital Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Hong Kong University of Science & Technology
The Hong Kong University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Daiwa Capital Markets (Hong Kong) Ltd.
Daiwa Capital Markets (Hong Kong) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
I-Mab
I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Kyler Lei
















